Abstract
The role of 1,25-dihydroxyvitamin D 3 (1,25-(OH)2 D 3 ) as a regulator of cell growth and differentiation is well recognized. Currently, 1,25-(OH)2 D 3 and vitamin D analogs are being evaluated for their therapeutic potential in the treatment of hyperproliferative disorders like cancer. In the present review, we will discuss several processes that might be involved in 1,25-(OH)2 D 3 - and vitamin D analog-mediated suppression of cancer cell growth. The effects on tumor cell proliferation, differentiation, apoptosis, angiogenesis, metastases, and parathyroid hormone-related peptide secretion will be highlighted. In addition, combination therapy with other tumor effective drugs will be addressed. Furtermore, we will focus on the potential drawbacks and the possible side effects of vitamin D compounds in the treatment of cancer.
Keywords: Anti Tumor, 1 25 Dihydroxyvitamin D3, Vitamin D Analogs, Cancer, Breast Carcinoma, Myeloid leukemia, Cervical Carcinoma, Osteosarcoma, Colon carcinoma, Ovarian carcinoma, Colorectal carcinoma/kwd, >, Pancreatic carcinoma, Fibrosarcoma, Pituitary Adenoma, Gall Bladder carcinoma, Prostate carcinoma, Intestine carcinoma, Renal cell carcinoma, Lung carcinoma, Squamous cell carcinoma, Lymphocytic leukemia, Transitional bladder carcinoma, Melanoma, Thyroid carcinoma, Medullary thyroid carcinoma, Uterine carcinosarcoma, Reduced angiogenesis, Tumor suppression, Reduction of metastases, Cell proliferation, Apoptosis, Cell differentiation, Angiogenesis, Parathyroid hormone related peptide PTH rP, Metasaes, Growth factor, Osteosarcoma human, Prostate human, Melanoma human, erythroleukemia cell line K 562, Parathyroid Hormone Related Peptide Secretion, Metastasis, cadherins fibronectin VCAM 1, Vitamin D Resistance, 22 Oxo 1 25 dihydroxyvitamin D3, Transforming growth factor
Current Pharmaceutical Design
Title: Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs
Volume: 6 Issue: 7
Author(s): Gert-Jan C.M. van den Bemd, Huibert A.P. Pols and Johannes P.T.M. van Leeuwen
Affiliation:
Keywords: Anti Tumor, 1 25 Dihydroxyvitamin D3, Vitamin D Analogs, Cancer, Breast Carcinoma, Myeloid leukemia, Cervical Carcinoma, Osteosarcoma, Colon carcinoma, Ovarian carcinoma, Colorectal carcinoma/kwd, >, Pancreatic carcinoma, Fibrosarcoma, Pituitary Adenoma, Gall Bladder carcinoma, Prostate carcinoma, Intestine carcinoma, Renal cell carcinoma, Lung carcinoma, Squamous cell carcinoma, Lymphocytic leukemia, Transitional bladder carcinoma, Melanoma, Thyroid carcinoma, Medullary thyroid carcinoma, Uterine carcinosarcoma, Reduced angiogenesis, Tumor suppression, Reduction of metastases, Cell proliferation, Apoptosis, Cell differentiation, Angiogenesis, Parathyroid hormone related peptide PTH rP, Metasaes, Growth factor, Osteosarcoma human, Prostate human, Melanoma human, erythroleukemia cell line K 562, Parathyroid Hormone Related Peptide Secretion, Metastasis, cadherins fibronectin VCAM 1, Vitamin D Resistance, 22 Oxo 1 25 dihydroxyvitamin D3, Transforming growth factor
Abstract: The role of 1,25-dihydroxyvitamin D 3 (1,25-(OH)2 D 3 ) as a regulator of cell growth and differentiation is well recognized. Currently, 1,25-(OH)2 D 3 and vitamin D analogs are being evaluated for their therapeutic potential in the treatment of hyperproliferative disorders like cancer. In the present review, we will discuss several processes that might be involved in 1,25-(OH)2 D 3 - and vitamin D analog-mediated suppression of cancer cell growth. The effects on tumor cell proliferation, differentiation, apoptosis, angiogenesis, metastases, and parathyroid hormone-related peptide secretion will be highlighted. In addition, combination therapy with other tumor effective drugs will be addressed. Furtermore, we will focus on the potential drawbacks and the possible side effects of vitamin D compounds in the treatment of cancer.
Export Options
About this article
Cite this article as:
van den Bemd C.M. Gert-Jan, Pols A.P. Huibert and van Leeuwen P.T.M. Johannes, Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs, Current Pharmaceutical Design 2000; 6 (7) . https://dx.doi.org/10.2174/1381612003400498
DOI https://dx.doi.org/10.2174/1381612003400498 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Transcriptional Control of Collagen I Gene Expression
Cardiovascular & Hematological Disorders-Drug Targets Iron Oxide Nanoparticles: An Insight into their Biomedical Applications
Current Medicinal Chemistry In Vitro Inhibitory Effect of Recombinant Human Calprotectin on Nalm6 Leukemia Cell Line
Anti-Cancer Agents in Medicinal Chemistry Application of Molecular Imaging Technologies in Antitumor Drug Development and Therapy
Current Pharmaceutical Design Melanoma Differentiation Associated Gene-7 (mda-7)/ Interleukin-24 (IL-24), mda-7/IL-24: Current Perspectives on a Unique Member of the IL-10 Family of Cytokines
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Early Bird Catches the Worm – Can Evolution Teach us Lessons in Fighting HIV?
Current HIV Research Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Current Pharmacogenomics Anti-Inflammatory Drugs and Prediction of New Structures by Comparative Analysis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging
Anti-Cancer Agents in Medicinal Chemistry Novel Anticancer Strategy Aimed at Targeting Shelterin Complexes by the Induction of Structural Changes in Telomeric DNA: Hitting two Birds with one Stone
Current Cancer Drug Targets Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis
Current Drug Targets - Inflammation & Allergy Therapeutic Benefit and Biological Importance of Ginkgetin in the Medicine: Medicinal Importance, Pharmacological Activities and Analytical Aspects
Current Bioactive Compounds circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma
Current Cancer Drug Targets Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Translational Research of Photodynamic Therapy with Acridine Orange which Targets Cancer Acidity
Current Pharmaceutical Design Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
Current Genomics PET Imaging to Monitor Cancer Therapy
Current Pharmaceutical Biotechnology Advancements in the Treatment and Repair of Tendon Injuries
Current Tissue Engineering (Discontinued) A Novel Method for Screening of Anti-Cancer Drugs: Availability of Screening in Acidic Medium
Recent Patents on Biomedical Engineering (Discontinued) Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)